Industry and Technology Division Council



Picture of Dr Bryan Hanley

Dr Bryan Hanley

President, due to retire 2017

Bryan is currently food specialist at The KTN. Prior to joining the KTN he worked in research institutes and in industry. Bryan held Board positions and worked in the UK, Ireland, Brussels and the US. Most recently he was the Director of Scientific Discovery at the Wm Wrigley Company in Chicago. His job titles have included Research Scientist, Contract Manager, Science Director, Associate Director Innovation, Director Scientific and Regulatory Affairs and Assistant Director Food. Bryan has a degree in chemistry and a PhD in biological chemistry. Bryan is a Fellow of The Royal Society of Chemistry, the Institute of Food Science and Technology and the Royal Society of Medicine. He is also a Chartered Chemist.

Bryan’s research interests include biomarkers, oral health, natural product chemistry and biosynthesis, analytical methods and chemistry/biology interactions.




Picture of Prof Roy Sandbach

Prof Roy Sandbach

President elect, due to become president in 2017

Roy is Director of the National Centre for Ageing Science & Innovation, at Newcastle University. This is a Northern Powerhouse initiative, and reflects national confidence in the world-leading ageing science skill & capability within the University. In addition, he has justed stepped down as Chair of the Innovation Board for the North East Local Enterprise Partnership. He developed the region’s innovation strategy as part of the Strategic Economic Plan.

Until2012, Roy held senior global R&D positions with the Procter & Gamble Company, developing innovation programmes across the world. He is a global expert in open innovation. He is a non-executive director of Arnia, a start-up business focused on beehive monitoring. 

Nationally, Roy is president-elect of the Royal Society of Chemistry Industry Council and chairs the National Smart Specialistion Hub, a government initiative to develop a coherent UK place-based innovation strategy. He holds visiting Professor positions with Northumbria University Business School, at Cranfield University and with Central St. Martin’s College of Art & Design, London.

Roy is from Sunderland and was educated at St. Aidan’s School. He read Chemistry at Imperial College and has a Ph.D. in physical electrochemistry from Newcastle University.




Picture of Dr David Lathbury

Dr David Lathbury

Elected Member, due to retire 2017

David received his first degree and PhD at Southampton with Phil Parsons. He then carried out post-doctoral work at Cornell (John McMurry) and Bath (Tim Gallagher) universities, before taking his first job in agro chemical discovery at Shell research at Sittingbourne. After a short spell in fine chemicals manufacturing in the NW, he joined SmithKline Beecham at Tonbridge working in chemical development. In 1998 he moved to Astra, which shortly became AstraZeneca, as director of Process Chemistry.




Picture of Mr Allan Malcolm

Mr Allan Malcolm

Elected Member, due to retire 2017

Allan has over 30 years in the chemical industry mainly in a technical sales and business development role. Allan has worked for several different organisations both large and SMEs, in the contract manufacturing sector except for a brief 4 year period in the 2000's when he was employed as a Business Manger for Brenntag in the pharma sector. Allan is currently working with Peptisyntha, part of Solvay, as Business development and Sales Manager with responsibility for the ROW. Peptisyntha are involved in the contract manufacture of Peptide API's and Peptiomentics.
In addition Allan has been very active in the RSC since joining in the mid 80's. He is currently involved with two interest groups associated with the Industry and Technology Division. Allan is the Honorary Treasurer of the Management Group and an active member of the Marketing Group.




Picture of Dr Mark J. Gronnow

Dr Mark J. Gronnow

Elected member, due to retire in 2018

Mark is currently manager of the Process Development Unit at the Biorenewables Development Centre (BDC).  The centre has been set up to bridge the gap between industry and academia by supporting SMEs, promoting the bioeconomy and demonstrating new technologies.  Within the BDC Mark and his team are responsible for the process equipment, supporting new users in developing their application on the wide range of equipment whilst coordinating the best technical and academic support.  
He completed his first degree and PhD in Chemistry at the University of York.  Between 2005 and 2010, he was technical manager for YorkTest Laboratories an SME in-vitro diagnostic laboratory.  In 2010, he re-joined the Green Chemistry Centre of Excellence as a technical manager responsible for delivery of the Carbon Trust Pyrolysis Challenge project.  This role evolved into technical operations manager for the GCCE, managing multiple projects and industrial engagements before moving to the BDC.




Picture of Dr Ian Bell

Dr Ian Bell

Elected Member, due to retire 2018

Ian is an organic chemist by training. Following a honours degree and PhD from University of Edinburgh he joined Exxon Chemical within the lubricant and fuel additive division and subsequently Infineum, the joint venture with Shell. During this time he was responsible for several component development, formulation research, product development and customer account management activities. Ian then joined BP (Castrol) where he managed product development activities and long range research activities including DTI funded research into reduced emission technology. He then moved to a strategy and planning role within BP Group Technology where new focused on technology management practices and definition of BP's biofuels strategy. In 2008 Ian joined Afton Chemical Ltd, one of the four global lubricant additive companies, as Research and Development Director for Engine Oils. This global role is responsible for research, component and polymer development, statistics and product development and has a globally dispersed team. As such he spends considerable time (too much!) on planes travelling around the world visiting the team, customers and OEM partners.




Picture of Dr Simon Turner

Dr Simon Turner

Appointed Member, due to retire 2017

Simon is founder of consulting company Canopus Management, focussing on strategy and technology commercialisation of life science technologies in early-stage companies.  Simon has an MA in Natural Sciences and a PhD in organic chemistry from the University of Cambridge.  After an early career as a bench scientist at Eli Lilly and ICI Agrochemicals, Simon joined 3i plc, where he was responsible for a number of venture capital investments across a range of sectors.  Moving into strategic management consulting, first at Arthur D Little and latterly Andersen Consulting, over 10 years Simon advised blue chip life science companies on issues related to business strategy, technology management & product commercialization.  In 2000, Simon became Chief Executive of Biotica Technology, an early stage venture-capital backed drug-discovery company based on microbial genetic engineering, which he led for five years.  He has since been involved as investor and advisor to research-based life science companies and IP owners in two investment firms and more recently through his own company.   He was also a Non-Executive Director at Green Biologics Ltd, a biobutanol company.




Picture of Dr Keith Layden

Dr Keith Layden

Co-opted Member, due to retire 2017

Keith is currently Chief Technology Officer for Croda. In this role he is responsible for global coordination of the group R&D activities and for the development and acquisition of novel technologies across all market sectors of relevance to the company. In previous roles in the organisation he has been responsible for the European Personal Care and Health Care businesses and has held operational responsibilities in the UK. Prior to joining Croda, Keith was a student at the University of Sheffield, graduating in Chemistry and Biochemistry in 1981 and being awarded his PhD in 1985. His additional external roles include Board membership of the Innovation Strategy Board for Chemistry Innovation, membership of the Industrial Biotechnology Leadership Forum, the Strategic Advisory Boards for Chemistry at the Universities of Nottingham, Newcastle and York and the Sheffield University Learning and Teaching Committee.




Dr Aurora Antemir

Industry Programme Manager (secretary)